Sten H. Vermund

Last updated

Sten H. Vermund is the Anna M.R. Lauder Professor of Public Health, and former Dean (2017-2022) of the Yale School of Public Health, and also serves as a Professor in Pediatrics at the Yale School of Medicine. He is a pediatrician and infectious disease epidemiologist focused on diseases of low and middle-income countries. [1]

Education and early career

Vermund, whose parents were immigrants from Norway, was born in Minnesota, and grew up in Wisconsin and California. He has a B.A. from Stanford University in Human Biology (1974, with Distinction) an M.D. from the Albert Einstein College of Medicine, an M.Sc. from the London School of Hygiene and Tropical Medicine in Community Health in Developing Countries (1981, awarded the Lalcaca Medal) and a Ph.D. from Columbia University in Epidemiology (1990; 2014 recipient of the Allan Rosenfield Alumni Award for Excellence in Public Health, Mailman School of Public Health).n [1]

His work with Einstein/Montefiore/NCI/CDC colleagues on HIV-HPV interactions among women in Bronx methadone programs motivated a change in the 1993 CDC AIDS case surveillance definition and inspired cervical cancer screening programs launched within HIV/AIDS programs around the world. He has contributed to key issues in parasitic disease epidemiology, sexually transmitted infections, child health in low income countries, HIV epidemiology, and strategies for HIV care and prevention in Africa, Asia, and resource-limited settings in the U.S., particularly in the southeast. His work as of 2022 includes COVID-19 risk reduction in schools and arts organizations, capacity building for the Institut National de Santé Publique in Chad funded by USAID, HIV research networks (HIV Prevention Trials Network and Implementation Science Coordination Initiative), social entrepreneurship in public health in India and the U.S., and NIH-funded research. 16

Related Research Articles

<span class="mw-page-title-main">Tropical medicine</span> Interdisciplinary branch of medicine

Tropical medicine is an interdisciplinary branch of medicine that deals with health issues that occur uniquely, are more widespread, or are more difficult to control in tropical and subtropical regions.

HIV/AIDS has been a public health concern for Latin America due to a remaining prevalence of the disease. In 2018 an estimated 2.2 million people had HIV in Latin America and the Caribbean, making the HIV prevalence rate approximately 0.4% in Latin America.

<span class="mw-page-title-main">Epidemiology of HIV/AIDS</span> Pandemic of HIV/AIDS

The global pandemic of HIV/AIDS began in 1981, and is an ongoing worldwide public health issue. According to the World Health Organization (WHO), by 2023, HIV/AIDS had killed approximately 40.4 million people, and approximately 39 million people were infected with HIV globally. Of these, 29.8 million people (75%) are receiving antiretroviral treatment. There were about 630,000 deaths from HIV/AIDS in 2022. The 2015 Global Burden of Disease Study estimated that the global incidence of HIV infection peaked in 1997 at 3.3 million per year. Global incidence fell rapidly from 1997 to 2005, to about 2.6 million per year. Incidence of HIV has continued to fall, decreasing by 23% from 2010 to 2020, with progress dominated by decreases in Eastern Africa and Southern Africa. As of 2023, there are about 1.3 million new infections of HIV per year globally.

<span class="mw-page-title-main">Cyclosporiasis</span> Medical condition

Cyclosporiasis is a disease caused by infection with Cyclospora cayetanensis, a pathogenic apicomplexan protozoan transmitted by feces or feces-contaminated food and water. Outbreaks have been reported due to contaminated fruits and vegetables. It is not spread from person to person, but can be a hazard for travelers as a cause of diarrhea.

<span class="mw-page-title-main">Needlestick injury</span> Accidental puncture of skin causing contamination

A needlestick injury is the penetration of the skin by a hypodermic needle or other sharp object that has been in contact with blood, tissue or other body fluids before the exposure. Even though the acute physiological effects of a needlestick injury are generally negligible, these injuries can lead to transmission of blood-borne diseases, placing those exposed at increased risk of infection from disease-causing pathogens, such as the hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV). In healthcare and laboratory settings globally, there are over 25 distinct types of blood-borne diseases that can potentially be transmitted through needlestick injuries to workers. In addition to needlestick injuries, transmission of these viruses can also occur as a result of contamination of the mucous membranes, such as those of the eyes, with blood or body fluids, but needlestick injuries make up more than 80% of all percutaneous exposure incidents in the United States. Various other occupations are also at increased risk of needlestick injury, including law enforcement, laborers, tattoo artists, food preparers, and agricultural workers.

<span class="mw-page-title-main">HIV/AIDS</span> Spectrum of conditions caused by HIV infection

The human immunodeficiency virus (HIV) is a retrovirus that attacks the immune system. It is a preventable disease. There is no vaccine or cure for HIV. It can be managed with treatment and become a manageable chronic health condition. While there is no cure or vaccine, antiretroviral treatment can slow the course of the disease and enable people living with HIV to lead long and healthy lives. An HIV-positive person on treatment can expect to live a normal life, and die with the virus, not of it. Effective treatment for HIV-positive people involves a life-long regimen of medicine to suppress the virus, making the viral load undetectable. Without treatment it can lead to a spectrum of conditions including acquired immunodeficiency syndrome (AIDS).

The National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), formerly the National Center for HIV, STD, and TB Prevention (NCHSTP) is a part of the Centers for Disease Control and Prevention and is responsible for public health surveillance, prevention research, and programs to prevent and control human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS), other sexually transmitted diseases (STDs), viral hepatitis, and tuberculosis (TB). Center staff work in collaboration with governmental and nongovernmental partners at community, State, national, and international levels, applying well-integrated multidisciplinary programs of research, surveillance, technical assistance, and evaluation.

HIV/AIDS in China can be traced to an initial outbreak of the human immunodeficiency virus (HIV) first recognized in 1989 among injecting drug users along China's southern border. Figures from the Chinese Center for Disease Control and Prevention, World Health Organization, and UNAIDS estimate that there were 1.25 million people living with HIV/AIDS in China at the end of 2018, with 135,000 new infections from 2017. The reported incidence of HIV/AIDS in China is relatively low, but the Chinese government anticipates that the number of individuals infected annually will continue to increase.

The Centers for Disease Control and Prevention (CDC), formed in 1946, is the leading national public health institute of the United States. It is a United States federal agency, under the United States Department of Health and Human Services. Its main goal is to protect public health and safety through the control and prevention of disease, injury, and disability in the US and internationally.

Frederick Wabwire-Mangen is a Ugandan physician, public health specialist and medical researcher. Currently he is Professor of Epidemiology and Head of Department of Epidemiology & Biostatistics at Makerere University School of Public Health. Wabwire-Mangen also serves as the Chairman of Council of Kampala International University and a founding member of Accordia Global Health Foundation’s Academic Alliance

<span class="mw-page-title-main">Wafaa El-Sadr</span> Egyptian physician

Wafaa El-Sadr is a Columbia University Professor and the director of ICAP at Columbia University, Columbia World Projects and the Center for Infectious Disease Epidemiologic Research (CIDER) at Columbia Mailman School of Public Health.

<span class="mw-page-title-main">Kevin Fenton</span> British epidemiologist

Kevin Andrew Fenton, is a public health physician and infectious disease epidemiologist. He is the London regional director at Office for Health Improvement and Disparities, regional public health director at NHS London and the statutory health advisor to the mayor of London, Sadiq Khan. He is the current president of the United Kingdom Faculty of Public Health and holds honorary professorships with the University College London and London School of Hygiene and Tropical Medicine. He is the 2024/25 president of the British Science Association.

Multiple sex partners (MSP) is the measure and incidence of engaging in sexual activities with two or more people within a specific time period. Sexual activity with MSP can happen simultaneously or serially. MSP includes sexual activity between people of a different gender or the same gender.

<span class="mw-page-title-main">Adaora Adimora</span> American doctor and academic (1956–2024)

Adaora Alise Adimora was an American doctor and academic. She was the Sarah Graham Kenan Distinguished Professor of Medicine and professor of epidemiology at the University of North Carolina School of Medicine. Her research centered on the transmission of HIV, as well as other sexually transmitted infections (STIs), among minority populations. Her work highlighted the importance of social determinants of HIV transmission and the need for structural interventions to reduce risk. In 2019, she became an elected member of the National Academy of Medicine in recognition of her contributions.

<span class="mw-page-title-main">Oni Blackstock</span> American physician and academic

Oni Blackstock is an American primary care and HIV physician, researcher, and founder of Health Justice, a racial and health equity consulting practice. She previously served as assistant commissioner for the Bureau of HIV for the New York City Department of Health, where she led the city's response to the HIV epidemic. Her research considers the experiences of women and people of color in healthcare. During the COVID-19 pandemic Blackstock shared advice on how people in New York City could maintain sexual health and slow the spread of COVID-19 as well as guidance for people with HIV and HIV care providers about the intersection of HIV and COVID-19.

Ann Marie Kimball is an American physician. She is known for being the pioneer of electronic disease surveillance for infectious disease outbreaks and pandemics. She is currently a Professor Emerita in the Department of Epidemiology at the University of Washington, a Consulting Fellow at the Chatham House Royal Institute of Foreign Affairs, and was a Strategic Consultant in Global Health at the Rockefeller Foundation. Kimball served as a technical and strategic lead for the Bill and Melinda Gates Foundation infectious disease surveillance strategy formation.

<span class="mw-page-title-main">Frits van Griensven</span> Dutch public health scientist and epidemiologist

Godefridus Johannes Petrus "Frits" van Griensven is a pioneering Dutch scientist in epidemiology, sociology and public health. Most of his work is on addressing the HIV epidemic among men who have sex with men and other HIV key populations.

<span class="mw-page-title-main">Denis Nash</span> American epidemiologist

Denis Nash is distinguished professor of epidemiology at the CUNY Graduate School of Public Health & Health Policy in the City University of New York. Nash is the founding executive director of the CUNY Institute for Implementation Science in Population Health. He is also the associate director of the NIH-funded Einstein, Rockefeller, CUNY Center for AIDS Research (CFAR).

References

[2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13]

  1. 1 2 "Sten H. Vermund, MD, PHD".
  2. "Insight: AIDS science leaping ahead, but will the money follow?". Reuters. 2012-09-06. Retrieved 2020-01-17.
  3. Hamid, Zainab (5 October 2016). "New dean named for School of Public Health". yaledailynews.com. Retrieved 2020-01-17.
  4. Snyder, Bill (9 April 2015). "Vermund named assistant vice chancellor for Global Health". Vanderbilt University. Retrieved 2020-01-17.
  5. Humphrey, Nancy (27 October 2016). "VIGH's Vermund named dean of Yale School of Public Health". Vanderbilt University. Retrieved 2020-01-17.
  6. "More gay, bi men with HIV receiving care, disparities remain". Reuters. 2017-04-13. Retrieved 2020-01-17.
  7. McNeil, Donald G. Jr. (2017-03-17). "Trump Plan Eliminates a Global Sentinel Against Disease, Experts Warn". The New York Times. ISSN   0362-4331 . Retrieved 2020-01-17.
  8. "Taking HIV drugs earlier could curb new infections". Archived from the original on May 13, 2011. Retrieved 2020-01-17.
  9. "A Life Refocused". Bethesda Magazine. 2007-11-15. Retrieved 2020-01-17.
  10. "1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults". www.cdc.gov. Retrieved 2020-01-17.
  11. "La incomprensión familiar daña la salud de los hijos homosexuales | elmundo.es salud". www.elmundo.es. Retrieved 2020-01-17.
  12. "Sten Vermund | The HIV Prevention Trials Network". www.hptn.org. Retrieved 2020-01-17.
  13. Kolata, Gina (1991-11-09). "BASKETBALL; For Heterosexuals, Diagnosis of AIDS Is Often Unmercifully Late". The New York Times. ISSN   0362-4331 . Retrieved 2020-01-17.